INVA
- Innoviva, Inc.
()
Overview
Company Summary
Innoviva, Inc. is a biopharmaceutical company that focuses on the development and commercialization of innovative respiratory medicines. The company primarily collaborates with pharmaceutical companies to help develop and market their respiratory products.
Innoviva's primary source of revenue comes from its long-standing partnership with GSK (GlaxoSmithKline), a global healthcare company. Through this collaboration, Innoviva has contributed to the development and commercialization of several respiratory medications, including some of GSK's key products in the field.
One of the key highlights of Innoviva's business model is its royalty-based revenue structure. The company receives royalties based on the sales of partnered products, providing a steady revenue stream. This allows Innoviva to focus on its core competency of supporting respiratory product development while leveraging its collaborations for financial growth.
In addition to its collaboration with GSK, Innoviva also has a portfolio of development-stage assets. These assets are early-stage respiratory drug candidates that could potentially expand the company's product offerings and royalty streams in the future. Innoviva works towards advancing these assets through partnerships or licensing agreements with other pharmaceutical companies.
Overall, Innoviva, Inc. plays a crucial role in the respiratory medicine industry by collaborating with pharmaceutical partners to develop and commercialize innovative treatments.